Venous thromboembolism in critically ill patients: Observations from a randomized trial in sepsis

Thrombosis and Haemostasis

Volumn 101, Issue 1, 2009, Pages 139-144

  Shorr, Andrew F ^a   Williams, Mark D ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Deep vein thrombosis; Heparin; Prevention; Pulmonary embolism; Sepsis

Indexed keywords

DROTRECOGIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; FIBRINOLYTIC AGENT; PROTEIN C; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SEPSIS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; TIME;

ADULT; AGED; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PRACTICE GUIDELINES AS TOPIC; PROTEIN C; RECOMBINANT PROTEINS; RISK ASSESSMENT; RISK FACTORS; SEPSIS; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 60849117247     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-07-0468     Document Type: Article

References (15)

1. Geerts W, Selby R. Prevention of venous thromboembolism in the ICU. Chest 2003; 124: 357S-363S.
2. Rocha AT, Tapson VF. Venous thromboembolism in intensive care patients, Clin Chest Med 2003; 24: 103-122.
3. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors, Crit Care Med 2005; 33: 1565-1571.
4. Ibrahim EH, Iregui M, Prentice D, et al. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 2002; 30: 771-774.
5. Patel R, Cook DJ, Meade MO, et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study, J Crit Care 2005; 20: 341-347,
6. Cook D, Douketis J, Crowther MA, et al. The diagnosis of deep venous thrombosis and pulmonary em- bolism in medical-surgical intensive care unit patients. J Crit Care 2005; 20: 314-319.
7. Bellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock, Crit Care Med 2004; 32: 858-873,
8. Levi M, Levy M, Williams MD, et al. Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 2007; 176: 483-490.
9. Cited at http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/ Measures/, accessed 25 Nov, 2007.
10. Cited at http://www.jointcommission.org/NR/rdonlyres/D6BD8CA5-3F3D-47A4- 8F72-79D242360494/0/DVT080604.pdf, accessed 25 Nov. 2007.
11. Geerts W, Cook D, Selby R, et al. Venous thromboembolism and its prevention in critical care. J Crit Care 2002; 17: 95-104.
12. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism, Chest 2007; 132: 936-945.
13. Holley AB, Moores LK, Jackson JL. Provider preferences for DVT prophylaxis. Thromb Res 2006; 117: 563-568.
14. Granger CB, Miller JM, Bovill EG, et al. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 1995; 91: 1929-1935.
15. Di Nisio M, Bijsterveld NR, Meijers JC, et al. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1582-1583.